Background
Dietary therapies are often perceived as natural treatments for disease. Certainly prior to the advent of medication, in particular antiepileptic drug medication, alternative forms of treatment were sought for treatment of the epilepsies. The earliest reports of the effects of starvation on epilepsy date back to the fifth century when Hippocrates described a man whose seizures were cured by abstaining from all food and drink. However subsequent first reports in the medical literature were by Guelpa and Marie who described the effect of complete fasting on the cessation of seizures. 1 This was also subsequently reported again in 1921 by
Geyelin, reporting that 20 out of 26 fasted patients had improved seizure control, 2 of whom remained seizure free for more than a year. 2 This work had been inspired by the work of an osteopath,
Conklin, who believed that epilepsy was caused by intoxication from the payers patches of the intestine and therefore advocated complete rest of the gut 3 . He fasted his patients for up to 25 days, reporting a 90% success rate in children under the age of 10 years, decreasing with age to 50% in adults. Such observations lead to considerable clinical and research interest and debate as to whether a similar metabolic state in the body to starvation could be obtained by other means. It was suggested by Wilder that a diet high in fat and low in carbohydrate may mimic the ketotic effect; driving the body to utilise the fat in the diet, so generating ketosis. 4 Subsequent work showed that 50% of Wilder's patients at The Mayo Clinic had significant seizure control using this method. Peterman subsequently also reported further successful results in 37 patients with 95% showing improvement when treated by the diet. 5 Subsequently the diet was shown to have benefits in epilepsy by several other workers and it was widely used up until the 1950s, probably coming out of favour in the late 1930s with the introduction of phenytoin and a presumption that an antiepileptic drug was likely to preclude any use for a change in the diet. Over the years it was used to a limited degree but there was great concern about the possible side effects and the burden on families of children trialled on the diet. The diet used was the classical form based on a ratio of fat to carbohydrate in the diet of 3 or 4:1. There was concern about abdominal side effects and the possible long-term side consequences such a diet may have on a child. Despite it being a dietary treatment it could not be thought of as a natural treatment and of course did provide dietary restrictions. There was also little in the way of scientific study to determine whether it was more beneficial than any other routine treatment in the effects on seizures. In 1971 a further modification of the classical diet was suggested in an attempt to lead to a greater palatability and less in the way of side effects. Huttenlocher reported the use of medium chain triglycerides (MCT) as an alternative fat choice, medium chain triglyceride being more ketogenic per calorie than long chain fat. 6 The main constituents of MCT are the medium chain length octanoic and decanoic fatty acids absorbed more efficiently than their long-term counterparts, being carried more directly to the liver in the portal blood. Following hepatic tissue uptake there are also further differences, long chain fat is firstly bound to carnitine, required to transport such across the mitochondrial membrane where beta oxidation and keto body synthesis occurs. Such a carnitine shuttle system is not required for medium chain fatty acids, which enter mitochondria directly. This more rapid and greater oxidation of medium chain fatty acids than their long chain counterparts results in a higher ketone production per kilocalorie of energy. Such an increase in ketogenic potential meant that less The ketogenic diet has been used for the treatment of epilepsy in childhood for almost 100 years. Although initial use was wide, the advent of antiepileptic drugs led to reduced utilisation. However, an apparently 'forgotten treatment' gained further popularity in the early 1990s when significant individuals gained benefit. This aside, although there are many open label trials to suggest benefit can be gained in children with drug resistant epilepsy it is only recently that definitive evidence from randomised controlled trials has become available. There continues to be a constant struggle with the demand for the resources required, and therefore availability and apparent management choice is limited. ß 2010 Published by Elsevier Ltd on behalf of British Epilepsy Association.
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Seizure j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / y s e i z fat was needed to be incorporated in the diet and therefore was supposedly more generous in protein and carbohydrate. Huttenlocher later showed that the ketogenic diet provided in this way was as effective as a 3:1 classical diet in producing ketosis and controlling seizures in a small number of children. 7 However there remained concern about efficacy and, indeed, tolerability. In view of concerns about side effects, Schwartz and colleagues developed a modified MCT diet using both MCT and long chain fat, providing only 30% of energy from MCT oil and an extra 30% from saturated fats (as compared to 60% MCT in the MCT diet). This became known as The John Radcliffe Diet. 8 Prior to the early 1990s there continued to be limited use of the ketogenic diet and a certain scepticism with regard to its efficacy. Renewed publicity was enhanced by the successful use of the diet in key individuals, most notably ''Charlie'' the son of Jim Abrahams, a film producer. There was consequently increased advocacy for its use, with development of ''The Charlie Foundation'' in the USA, and the production of the film ''Do no harm'' starring Meryl Streep telling their story.
Evidence base for the use of the ketogenic diet
There was much in the way of open label data to suggest efficacy of the ketogenic diet in the treatment of epilepsy; a systematic review published in 2000 concluded there was sufficient evidence to suggest that the diet was efficacious in children with intractable epilepsy. However it was noted that there was a lack evidence from controlled trials. 9 Only 11 studies were eligible for review, all 11 were observational, only 2 prospective and 9 of the 11 studies were from a single institution. This institution was The John Hopkins Hospital in Baltimore, which had advocated the diet's use over many years. A further systematic review, published in 2006, reviewed 14 studies with the inclusion criteria that there required to be at least 6 months follow-up following initiation of the diet. 10 This review reached a similar conclusion with a total collective population of 972 (studies reviewed since 1990); at 6 month follow up 15.6% collectively were seizure free and 33% of children had more than a 50% reduction of seizures. However again it was highlighted that there were no prospective controlled trials; and this was further emphasised by a Cochrane review published in 2003, which also failed to find any randomised controlled trial with regard to assessing the efficacy of the ketogenic diet.
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More recently the first randomised controlled trial has been published with the use of the ketogenic diet in drug resistant epilepsy in childhood. 12 This study randomised 145 children aged between 2 and 16 years, who had at least daily seizures and failed to respond to at least 2 antiepileptic drugs. Children in this study were randomly assigned to receive a ketogenic diet either after a 4-week baseline period of seizure documentation or after a further 3-month delay where there was no change in treatment (the control group). At 3 months data for 103 children were available for analysis, 54 on the ketogenic diet and 49 controls. Compared to baseline, there was a 38% reduction in mean seizure frequency for the diet group and a 37% increase for controls (a mean percentage difference between the groups of 75%). Twenty-eight children in the diet group achieved a responder rate of greater than 50% reduction in seizures compared to only 4 controls, a difference which reached significance. A further aim of this study was to determine whether there was any difference in efficacy between the classical and the MCT diets. At no time point, namely 3, 6 or 12 months was there any significant difference in efficacy, either in the percentage of baseline seizures or in responder rates. 13 There has been another randomised control study published since this time, also a double blind study involving children with Lennox-Gastaut Syndrome.
14 Children were initially fasted and subsequently clinical and EEG events were documented. All children in the study received a ketogenic diet, but 50% of them received a saccharin drink and 50% a glucose drink, those with the latter assumed to break ketosis. Children were unaware, as were parents, which of the diets they were receiving. They were all inpatients, seizure frequency was documented and EEG was performed prior to the start of the dietary treatment. At 6 days children were reassessed and subsequently crossed over to receive the alternative drink. Seizure count and EEG data were recorded at this point and again after a further 6 days. No significant difference in electrical or clinical events were noted between the ketogenic diet and the non-ketogenic diet (glucose drink) periods, but the methodology may have precluded ultimate significance. The baseline seizure frequencies were documented after a 24-h period of fasting and subsequently children receiving the glucose drink did not break ketosis and therefore could not be assumed to be on a normal diet. Tolerability of the diet has also been a concern and of course it is necessary for it to be palatable. In the short term the randomised controlled trial reported confirming data from open label studies that vomiting, diarrhoea, constipation and hunger were the most commonly reported side effects, however the majority could be alleviated by dietary manipulation and therefore very few withdrawals prior to or at the 3-month period were due to these side effects. 12 Further no significant difference was seen between the 2 types of diet with regard to side effects at 3 or 12 months. 13 There is no question the behaviour issues seen around feeding times were a problem, but behaviour problems per se did not appear to be a contraindication to the diet. Further, gastro-oesophageal reflux may be exacerbated by a high fat diet in view of the delayed gastric emptying and needs to be considered prior to initiation. Children do appear to bruise more easily and therefore require careful monitoring in view of inaccurate conclusions that may be drawn with the occurrence of spontaneous bruising. 15 This is likely to be due to prolonged bleeding times and platelet aggregation abnormalities, but these do not preclude safety during surgical procedures. 16 Raised blood cholesterol is also seen on all children but raised blood triglycerides do not occur on the MCT diet. The exact long-term implications of this remain unclear. Long-term a main concern has been that of the occurrence of renal stones, children who are non-ambulant and the very young with a high calcium excretion being those who are most at risk. 17 Additionally, growth may be impaired. 18, 19 There appears to be negative change in the Z score, that is deviation of the height velocity away from the normal trajectory, the longer the duration of the diet, particularly noticeable in the very young. At each stage the risk benefit ratio with regard to a child remaining on the diet needs to be assessed.
In whom is it suitable?
As outlined above, the ketogenic diet cannot be considered to be a 'natural treatment'. It can have side effects like many of the anticonvulsant medications. Further it requires a high degree of dietary supervision, and for the children only to eat according to the prescription. Although a varied menu can be provided within the requirements, it is still restrictive to some degree on lifestyle. For these reasons, it should be considered only in drug resistant epilepsy as a possible management option after failure of at least two AEDS. Syndrome specific efficacy has been suggested in Doose syndrome, 20 Dravet syndrome 21 and West syndrome 22 ; in these syndromes the diet may therefore be considered earlier in management rather than later. However, there are certain metabolic conditions with epilepsy as a symptom for which the diet would be the treatment of choice. These are conditions where the individual is unable to use glucose as the primary fuel, and ketones therefore provide an alternative e.g. Glucose transporter defects, pyruvate dehydrogenase deficiency. An understanding of these conditions has led to the suggestion that glucose transporter defects may be responsible for a wider range of epilepsies, and therefore that the ketogenic diet be a suitable treatment for a larger population. 23 Likewise the diet will be contraindicated in children with metabolic conditions where they are unable to utilise ketones, and require glucose e.g. pyruvate decarboxylase deficiency and fatty acid oxidation defects. 24 
Alternative diets
The ketogenic diet either in the classical or the MCT form remains restrictive and prescriptive. It requires careful monitoring by a dietician, particularly with its use in children. Use in adults has been attempted, but in view of its restrictions has been extremely difficult and it has been noted that even where benefit is seen, adults are not able to continue with the ketogenic diet in the immediate term. 25 Considering this, alternative ways of generating ketosis and therefore administering the diet have been considered. A modified Atkins Diet is very similar to the ketogenic diet with high fat and low carbohydrate but there remains unlimited protein within the diet therefore allowing more in the way of palatability.
In a limited open label study in adults aged 18-50 years of age, 10 discontinued the diet before 3 months, but 40% had more than a 50% reduction of seizures at this time. 26 A larger study of children in Korea showed a similar efficacy and similar retention rates. 27 Certainly this is a less restrictive diet that may have a role to play in teenagers and adults. An alternative way of generating ketosis has been suggested using a low glycaemic diet. The glycaemic index is calculated from the incremental area under the blood glucose curve after feeding, more complex sugars therefore not leading to a rapid rise in blood sugar. In a series of children reported in an open label fashion in Boston, 50% were demonstrated to have more than a 50% of reduction of seizures at 3 months. 28 The authors suggest this approach could be trialled in the first instance and if some benefit were demonstrated, the ketogenic diet could be used subsequently. This is a diet that could also be trialled in older individuals, to allow greater palatability.
5. How does it work -will we ever be able to use 'a pill'
Research through basic science has attempted to determine the possible anitepileptogenic (and potentially neuroprotective) effects of the diet. 29, 30 Many systemic and metabolic changes are induced once a child initiates the diet, but as with many of the antiepileptic medications, which effects determined in vitro remain the most relevant in vivo is unclear. Early study suggested that seizure reduction was related to the degree of ketosis; the relationship is not direct however and although acetone has been shown to prevent acutely provoked seizures in animals there is no evidence that ketone bodies can have a direct effect on synaptic transmission or neuronal excitability. Experimental data have also suggested the diet may increase mitochondrial biogenesis and energy metabolism, or a possible role for polyunsaturated fatty acids adminstered as part of the diet. 29 It is likely that the underlying changes induced by the ketogenic diet responsible for the antiepileptic effect are multiple and synergistic, 31 and therefore it appears unlikely that in the immediate future, the diet will be replaced by a simple medication or pill alone.
Current position on the use of the ketogenic diet in epilepsy
Key to the implementation of the ketogenic diet is the availability of a skilled dietician as part of a ketogenic diet team, to ensure dietary and calorie intake appropriate to the age and medical condition of the child. The diet must be nutritionally adequate with vitamin, mineral and tracer element supplementation where required. There is a general consensus that the ketogenic diet or equivalent should be available as part of any epilepsy service, and in certain epilepsy syndromes offered earlier rather than later. 24 Evidence is now in favour of initiation appropriate to service availability; outpatient intiation without fasting is currently considered appropriate where adequate support is available. However, despite the increasing evidence of efficacy, and increasing awareness amongst families, there still remains lack of choice for either a family or professional team owing to lack of resources required. Timing of the offer of a ketogenic diet continues to be driven by waiting lists, and referral patterns skewed by availability. 32 It is generally accepted that such a service continues to require provision through a paediatric neurology service until wider experience is achieved. One approach has been for charitable organisations to support services in some way, not least by funding of dieticians at least in the short term. Further, such organisations can provide additional support in tandem with professional services. Specific funding streams for provision of such services however do need to be determined.
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